Gene · 269
AMHR2: anti-Mullerian hormone receptor type 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AMHR2: anti-Mullerian hormone receptor type 2. Genes, record 269. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/269
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16671 | Anti-Muellerian hormone type-2 receptor | 573 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents52
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37634 | Q16671 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1651 | Q16671 | Espacenet |
| US 12421295 B2 | 2025-09-23 | 50 | Q16671 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 382 | Q16671 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 382 | Q16671 | Espacenet |
| US 12357593 B2 | 2025-07-15 | 1 | Q16671 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1651 | Q16671 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 5542 | Q16671 | Espacenet |
| US 12240887 B2 | 2025-03-04 | 180 | Q16671 | Espacenet |
| JP 2025004103 A | 2025-01-14 | 42 | Q16671 | Espacenet |
1 to 10 of 52
See all 52 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants521
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AMHR2 papers | Newest fiscal year |
|---|---|---|---|
| R01HD105818 | Structure-function analysis of Mullerian Inhibiting Substance (MIS) | 5 | 2025 |
| K12HD000849 | Reproductive Scientist Development Program | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 4 | 2025 |
| P51OD011106 | Wisconsin National Primate Research Center Support | 4 | 2025 |
| T32CA071345 | Training Program in Cancer Biology and Therapeutics | 4 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 3 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 3 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 521Source NIH's project files
See all 521 nih grantsPapers889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AAV-DJ Enables Targeted Gene Modulation in Human Ovarian Cells. | bioRxiv | 2026 | 42818815 | PubTator, text mining | PubMed |
| Case Report: Mixed gonadal dysgenesis with Müllerian remnants mimicking a prostatic utricle in a child with 45,X/46,XY/47,XYY mosaicism. | Front Pediatr | 2026 | 42741448 | PubTator, text mining | PubMed |
| Clinical, hormonal, and genetic spectrum of cryptorchidism: a comprehensive evaluation of patients referred for pediatric endocrinological assessment. | J Pediatr Endocrinol Metab | 2026 | 42638530 | PubTator, text mining | PubMed |
| Microscopic Müllerian Duct Remnants in a 46,XY Individual with Genetically Confirmed 17α-Hydroxylase/17,20-Lyase Deficiency: an Unexpected Histopathological Finding. | J Clin Res Pediatr Endocrinol | 2026 | 42619468 | PubTator, text mining | PubMed |
| A novel AMHR2 gene mutation causing transverse testicular ectopia: A rare case report and literature review. | Urol Case Rep | 2026 | 42541142 | PubTator, text mining | PubMed |
| Inhibition of IGFBP4 in Granulosa Cells Improves Reproductive Performance and Maintains Fertility With Age via YAP Signaling. | Adv Sci (Weinh) | 2026 | 42460631 | PubTator, text mining | PubMed |
| The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy. | J Assist Reprod Genet | 2026 | 42322505 | PubTator, text mining | PubMed |
| Functional and transcriptomic insights into 46,XY disorders of sex development associated with NR5A1 gene variants. | Biol Sex Differ | 2026 | 42260572 | PubTator, text mining | PubMed |
| Enhanced exosomes for fertility protection against chemotherapy-induced ovarian damage. | NPJ Regen Med | 2026 | 42243142 | PubTator, text mining | PubMed |
| Diagnostic Criteria and Genetic Basis of Polycystic Ovary Syndrome: A Narrative Review. | Metabolites | 2026 | 42042922 | PubTator, text mining | PubMed |
1 to 10 of 889
See all 889 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/269
GET https://conductscience.org/api/genes/v1/269/patents?page=2